B&G Foods, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data B&G Foods, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2026
Revenue	1,391	1,668	1,701	1,660	1,968	2,056	2,163	2,062	1,932	1,829
Cost of revenue	943	1,206	1,351	1,277	1,486	1,619	1,753	1,607	1,511	1,430
Gross profit	429	441	350	383	482	437	410	456	422	399
Selling, general and administrative	157	183	167	161	186	196	190	196	188	195
Operating income	253	238	340	204	276	196	98.6	80.4	-177	97.1
Interest expense	74.5
Other non-operating income	1.58	3.1	3.59	1.16	2.56	4.46	7.38	3.78	4.22	4.75
Pre-tax income	177	148	222	106	177	93.7	-18.9	-67.1	-331	-47.7
Income tax	67.6	-69.4	49.8	29.3	45.4	26.3	-7.54	-0.94	-79.3	-4.48
Net income	109	217	172	76.4	132	67.4	-11.4	-66.2	-251	-43.3
EBITDA	290	287	394	263	340	279	179	150	-109	163
EPS, basic	1.73	3.27	2.61	1.17	2.06	1.03	-0.16	-0.89	-3.18	-0.54
EPS, diluted	1.73	3.26	2.60	1.17	2.04	1.02	-0.16	-0.89	-3.18	-0.54
Shares, basic (weighted)	63.2	66.5	66.1	65	64.2	65.1	70.5	74.3	79	79.8
Shares, diluted (weighted)	63.4	66.7	66.3	65	64.6	65.7	70.5	74.3	79	79.8
Dividend per share	1.73	1.86	1.89	1.90	1.90	1.90	1.62	0.76	0.76	0.76

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2026
Cash and equivalents	28.8	207	11.6	11.3	52.2	33.7	45.4	41.1	50.6	56.3
Receivables	119	141	152	144	133	145	150	143	172	141
Inventory	357	502	401	472	493	610	726	569	511	421
Other current assets	26.4	20.1	20	25.4	43.6	38.2	37.6	41.7	38.3	53.4
Total current assets	542	887	586	662	737	834	1,019	803	781	740
Property, plant and equipment	245	272	283	305	372	341	318	302	278	253
Lease right-of-use assets				38.7	32.2	65.2	65.8	70	55.4	51
Goodwill	614	649	584	596	645	645	619	619	548	544
Intangible assets	1,629	1,748	1,596	1,615	1,971	1,927	1,788	1,628	1,286	1,191
Other non-current assets	4.63	1.62	4.2	3.28	5.95	6.92	19.1	23.5	34.8	45.9
Total assets	3,044	3,561	3,058	3,228	3,768	3,829	3,842	3,463	2,994	2,835
Accounts payable	98	122	140	115	127	130	128	124	113	108
Accrued liabilities	62.4	48.1	55.7	55.7	77.5	66.9	64.1	83.2	84	78.4
Short-term debt	10.5			5.63			50	22	5.63	4.5
Total current liabilities	206	201	258	217	246	244	272	262	237	223
Long-term debt	1,715	2,218	1,639	1,874	2,334	2,268	2,339	2,023	2,015	1,946
Lease liabilities				32	24	55.6	51.7	53.7	37.7	34.6
Other non-current liabilities	21.4	24.9	24.5	37.6	38.9	30	20.6	20.8	11.8	10.9
Total liabilities	2,258	2,680	2,158	2,415	2,936	2,908	2,973	2,628	2,469	2,382
Total debt	1,726	2,218	1,639	1,880	2,334	2,268	2,389	2,045	2,020	1,950
Paid-in capital	388	267	116			3.55		47
Retained earnings	417	634	807	844	867	934	877	785	529	437
Other comprehensive income	-19.4	-20.8	-23.5	-31.9	-35.6	-18.2	-9.35	2.6	-4.74	15
Shareholders' equity	786	881	900	813	832	920	868	835	525	453
Total equity	786	881	900	813	832	920	868	835	525	453
Total liabilities and equity	3,044	3,561	3,058	3,228	3,768	3,829	3,842	3,463	2,994	2,835
Shares outstanding	66.4	66.5	65.6	64	64.3	68.5	71.7	78.6	79.1	80

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2026
Net income	109	217	172	76.4	132	67.4	-11.4	-66.2	-251	-43.3
Depreciation and amortization	37.3	49.2	53.6	58.7	63.7	82.9	80.5	69.6	68.6	66.2
Stock-based compensation	5.8	4.62	3.03	2.59	10.6	5.38	3.92	7.19	8.66	13.3
Deferred income tax	56.2	-80.5	-1.49	20.4	42.6	7.27	-26.9	-26.4	-99.1	-1.82
Change in receivables	-45.8	-18	-12.9	13.9	10.8	-12.5	-5.85	7.33	-30.3	32.1
Change in inventory	2.4	-140	88	-57.4	17.3	-117	-125	89.9	43.2	-23.3
Cash from operations	290	37.8	209	46.5	281	93.9	5.96	248	131	101
Capital expenditures	-42.4	-59.8	-41.6	-42.4	-26.7	-43.6	-22.3	-25.7	-27.3	-30.6
Acquisitions	-439	-163	-30.8	-82.4	-542		-27.3	0	0
Cash from investing	-481	-221	348	-125	-569	-42.8	-39.1	81.6	-27.7	39.3
Debt issued		914		1,000	300			550
Debt repaid	-150	-234	-650	-700	-78.4		0	-632	-266	-37.8
Stock issued	332	0.11	0.06		2.42	110	65.2	73.8	0	0
Share buybacks			-26.9	-34.7
Dividends paid	-101	-124	-125	-124	-122	-123	-133	-56	-60	-60.6
Cash from financing	216	359	-753	77.7	328	-69.8	45.3	-334	-93	-136
Exchange rate effect	-0.87	1.08
Net change in cash	23.6	178	-195	-0.33	40.9	-18.5	11.8	-4.35	9.49	5.71
Free cash flow	247	-22	168	4.15	255	50.3	-16.3	222	104	70.7
Interest paid	69.8	75.8	102	88	97.4	102	119	142	142	149
Income taxes paid	15.4	17.2	4.67	47.5	9.81	5.65	25.6	24.8	21.2	5.77

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to July 4, 2026; growth uses fiscal years. Valuation uses the share price of $3.10 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	21.5%	Gross profit / revenue.
Operating margin	3.6%	Operating income / revenue.
EBITDA margin	7.1%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	-4.6%	Pre-tax income / revenue.
Net margin	-4.0%	Net income / revenue.
FCF margin	3.6%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	5.0%	Cash from operations / revenue.
Return on equity (ROE)	-17.9%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	-2.1%	Net income / average total assets.
Return on invested capital (ROIC)	2.1%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	10.7%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.7%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	1.4%	Capital expenditures / revenue.
D&A / revenue	3.5%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-5.4%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-5.4%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	-1.5%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-5.5%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-0.9%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	-3.7%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income CAGR, 3y	-0.5%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	-18.9%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA CAGR, 3y	-3.0%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	-13.6%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-22.5%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	157.1%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	-18.5%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-31.7%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 5y	-22.6%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	0.0%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	-22.2%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	-16.7%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-13.7%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-19.5%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	-11.4%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-5.3%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-9.6%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-5.5%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	0.9%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	4.2%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	4.3%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.62x	Current assets / current liabilities.
Quick ratio	0.97x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.79x	(Cash + short-term investments) / current liabilities.
Debt / equity	6.38x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	75.1%	Total debt / total assets.
Liabilities / assets	88.2%	Total liabilities / total assets.
Net debt	$1.93B	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	15.4x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Working capital	$460.1M	Current assets - current liabilities.
Goodwill and intangibles / assets	54.1%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$1.42B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.53x	Revenue / average total assets.
Fixed asset turnover	7.74x	Revenue / average property, plant and equipment.
Inventory turnover	3.55x	Cost of revenue / average inventory.
Days inventory	103 days	365 x average inventory / cost of revenue.
Receivables turnover	13.3x	Revenue / average receivables.
Days sales outstanding	27 days	365 x average receivables / revenue.
Days payables	33 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	97 days	Days inventory + days sales outstanding - days payables.
Capex / operating cash flow	28.1%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$0.87	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$21.82	Revenue / diluted weighted shares.
FCF per share	$0.79	Free cash flow / diluted weighted shares.
Operating cash flow per share	$1.09	Cash from operations / diluted weighted shares.
Book value per share	$4.86	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$17.52	Tangible book value / shares outstanding.
Cash per share	$7.28	(Cash + short-term investments) / shares outstanding.
Dividends / FCF	95.5%	Dividends paid / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$252.0M	Share price x shares outstanding.
Enterprise value	$2.18B	Market cap + total debt - cash - short-term investments.
P/S	0.14x	Market cap / revenue.
P/B	0.64x	Market cap / shareholders' equity. Only when equity is positive.
P/FCF	3.94x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	2.84x	Market cap / cash from operations, when positive.
EV/Sales	1.23x	Enterprise value / revenue.
EV/EBIT	34.7x	Enterprise value / operating income, when both are positive.
EV/EBITDA	17.5x	Enterprise value / EBITDA, when both are positive.
EV/FCF	34.2x	Enterprise value / free cash flow, when both are positive.
FCF yield	25.4%	Free cash flow / market cap.
Earnings yield	-28.1%	Net income / market cap (the inverse of P/E).
Dividend yield	24.2%	Dividends paid over the period / market cap.
Shareholder yield	24.2%	(Dividends paid + share buybacks) / market cap.

What was B&G Foods, Inc.'s revenue in fiscal 2026?

B&G Foods, Inc. reported revenue of $1.83B for fiscal 2026, 5.4% lower than the year before.

Was B&G Foods, Inc. profitable in fiscal 2026?

No. It reported a net loss of $43.3M.

How much free cash flow did B&G Foods, Inc. generate in fiscal 2026?

Cash from operations of $101.4M minus capital expenditures of $30.6M left free cash flow of $70.7M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to B&G Foods, Inc.